Sigilon Therapeutics, Inc.
SGTXDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821323
Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Sigilon Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 16 | 1 | −15 |
| Shares | 1.18M | 200 | −1.18M (−100.0%) |
| Value | $26.6M | $4.49K | −$26.6M (−100.0%) |
New holders (1)
Institutions that held Sigilon Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 200 | $4.49K | 0.00% |
Sold out (16)
Institutions that held Sigilon Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Flagship Pioneering Inc. | 797,720 | $18.0M |
| Canada Pension Plan Investment Board | 114,244 | $2.57M |
| FMR LLC | 78,796 | $1.77M |
| HarbourVest Partners LLC | 56,979 | $1.28M |
| Yakira Capital Management, Inc. | 39,746 | $894.7K |
| State of Wisconsin Investment Board | 39,202 | $882.4K |
| Vanguard Group Inc | 23,144 | $521.0K |
| CSS LLC | 13,292 | $299.2K |
| Bridgeway Capital Management, LLC | 9,615 | $216.4K |
| Morgan Stanley | 6,418 | $144.5K |
| Tower Research Capital LLC (TRC) | 2,069 | $46.6K |
| BlackRock Inc. | 253 | $5.70K |
| Royal Bank of Canada | 131 | $3.00K |
| Wells Fargo & Company | 8 | $180 |
| Advisor Group Holdings, Inc. | 7 | $157 |
| Bank of America Corp | 1 | $23 |